RMTI Share Price

Open 6.64 Change Price %
High 6.72 1 Day -0.10 -1.51
Low 6.48 1 Week 0.22 3.50
Close 6.51 1 Month 0.84 14.81
Volume 150584 1 Year -4.59 -41.35
52 Week High 11.20
52 Week Low 3.55
RMTI Important Levels
Resistance 2 6.73
Resistance 1 6.64
Pivot 6.57
Support 1 6.38
Support 2 6.29
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.70 0.20%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
RITT 0.06 -45.45%
More..

Rockwell Medical, Inc. (NASDAQ: RMTI)

RMTI Technical Analysis 2
As on 2nd Dec 2016 RMTI Share Price closed @ 6.51 and we RECOMMEND Sell for LONG-TERM with Stoploss of 7.36 & Strong Buy for SHORT-TERM with Stoploss of 6.18 we also expect STOCK to react on Following IMPORTANT LEVELS.
RMTI Target for December
1st Target up-side 8.22
2nd Target up-side 9.42
3rd Target up-side 10.62
1st Target down-side 4.78
2nd Target down-side 3.58
3rd Target down-side 2.38
RMTI Other Details
Segment EQ
Market Capital 141224960.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.rockwellmed.com
RMTI Address
RMTI
30142 Wixom Road
Wixom, MI 48393
United States
Phone: 248-960-9009
Fax: 248-960-9119
Interactive Technical Analysis Chart Rockwell Medical, Inc. ( RMTI NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Rockwell Medical, Inc.
RMTI Business Profile
Rockwell Medical, Inc., formerly Rockwell Medical Technologies, Inc., manufactures hemodialysis concentrate solutions and dialysis kits, and it sells, distributes and delivers these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States, as well as internationally primarily in Asia, Latin America and Europe. Hemodialysis duplicates kidney function in patients with failing kidneys also known as End Stage Renal Disease (ESRD). ESRD is an advanced-stage of chronic kidney disease (CKD) characterized by the irreversible loss of kidney function. Its dialysis solutions (also known as dialysate) are used to maintain life, removing toxins and replacing nutrients in the dialysis patient�s bloodstream. As of December 31, 2011, it was licensed and was developing renal drug therapies. During the year ended December 31, 2011, it acquired an abbreviated new drug application (ANDA) for a generic version of an intravenous Vitamin-D analogue, calcitriol.